Finance

Lists
Outlook: 33.3% bullish·0.0% bearish
Go to analysis
KMBB34:BVMF
Kimberly-Clark Corporation Bdr
R$614.25
0.00%
(0.00) 1D
Nov 5, 12:37:24 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for KMBB34...
Mkt. cap
67.97B
Avg. vol.
59.00
Volume
0.00
52-wk high
R$614.25
52-wk low
R$458.97
Shares outstanding
613.64M
No. of employees
36K
Mkt. cap
67.97B
Avg. vol.
59.00
Volume
0.00
52-wk high
R$614.25
52-wk low
R$458.97
Shares outstanding
613.64M
No. of employees
36K
News stories
From web sources and news partners
Profile
Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes. Founded in Neenah, Wisconsin, in 1872 and based in the Las Colinas section of Irving, Texas, since 1985, the company operated its own paper mills around the world for decades, but closed the last of those in 2012. With recent annual revenues topping $18 billion per year, Kimberly-Clark is regularly listed among the Fortune 500. As of March 2020, the company had approximately 40,000 employees. Wikipedia
About Kimberly-Clark Corporation Bdr
CEOMichael D. Hsu
Employees36K
Founded1872
HeadquartersIrving, Texas, United States
SectorConsumer Staples
IndustryHousehold goods
Last report
Nov 5, 2026
Fiscal period
Q3 2026
$1.70 / $1.66
+2.45%beat
Revenue / Est. (USD)
4.13B / 4.13B
+0.19%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
4.08B
4.16B
4.19B
4.13B
Cost of goods sold
2.57B
2.59B
2.56B
2.66B
Cost of revenue
2.57B
2.59B
2.56B
2.66B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
968.00M
900.00M
862.00M
782.00M
Operating expense
972.00M
758.00M
829.00M
786.00M
Total operating expenses
3.54B
3.34B
3.39B
3.45B
Operating income
537.00M
818.00M
796.00M
684.00M
Other non operating income
49.00M
-15.00M
-12.00M
-13.00M
EBT including unusual items
495.00M
738.00M
627.00M
500.00M
EBT excluding unusual items
585.00M
800.00M
790.00M
661.00M
Income tax expense
104.00M
164.00M
217.00M
95.00M
Effective tax rate
21.01%
22.22%
34.61%
19.00%
Other operating expenses
4.00M
-142.00M
-33.00M
4.00M
Net income
499.00M
665.00M
345.00M
1.79B
Net profit margin
12.23%
15.97%
8.24%
43.37%
Earnings per share
1.86
1.97
2.12
1.70
Interest and investment income
6.00M
5.00M
4.00M
16.00M
Interest expense
-60.00M
-58.00M
-53.00M
-48.00M
Net interest expenses
-54.00M
-53.00M
-49.00M
-32.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
601.00M
980.00M
994.00M
817.00M
Gain or loss from assets sale
-3.00M
-19.00M
12.00M
-1.49B
Upcoming events
AI content may include mistakes. Learn more
Google apps